[2LBA-100] The Role of PP2A inhibitor SET/I2PP2A in Gastric Cancer

〇Shuhei Enjoji¹, Ryotaro Yabe¹, Kazuhiro Yoshimura¹, Hideyoshi Kawasaki¹, Masashi Sakurai², Yusuke Sakai², Hiroko Takenouchi³, Shigefumi Yoshino⁴, Shoichi Hazama³, Hiroaki Nagano³, Hiroko Ohshima⁵, Masanobu Ohshima⁵, Michael P. Vitek^6,7, Tetsuya Matsuura⁸, Yoshitaka Hippo⁹, Tatsuya Usui¹⁰, Takashi Ohama¹, Koichi Sato¹ (1.Lab. of Vet. Pharm., Vet. Med., Univ. of Yamaguchi, 2.Lab. of Vet. Path., Vet. Med., Univ. of Yamaguchi, 3.Dept. of Gastroentero., Breast and Endo. Surg., Yamaguchi Univ. Grad. Sch. of Med, 4.Onco. Cent., Yamaguchi Univ. Hosp., 5.Divis. of Gene., Cancer Res. Instit., Kanazawa Univ., 6.Dept. of Neuro., Duke Univ. Med. Cent., 7.Oncotide Pharma., Inc., Res. Triangle Park, 8.Dept. of Gastroentero. and Hepato., Yokohama City Univ. Sch. of Med., 9.Chiba Cancer Cent., 10.Lab. of Vet. Toni., Vet. Med., Univ. of Yamaguchi)

Gastric cancer, PP2A, SET/I2PP2A, E2F1